Beyond Effectiveness: Impact of Cladribine on Patient-Reported Outcomes and Quality of Life in Latin American Populations With Multiple Sclerosis
CLAD demonstrates an effectiveness and safety profile consistent with clinical trials in Latin American RMS populations, also improving PROs and functional outcomes, supporting its use as a viable treatment option.
Authors
- Patricio Correa
- Bernardita Soler (ORCID: https://orcid.org/0000-0002-8143-4497)
- Carolina Pelayo
- Irene Treviño‐Frenk
- C Carcamo
- Adriana J. Carra
- Ethel Ciampi (ORCID: https://orcid.org/0000-0002-7330-5433)
- Macarena Vásquez
- Juan de la Barra
- Adolfo del Canto
- Alejandra Martinez
- Ana Reyes
- Lorena Garcia
Institutions
- Hospital Británico (UY)
- Pontificia Universidad Católica de Chile (CL)
- Christus Health (US)
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- Fundacion Favaloro Hospital Universitario (AR)
- Hospital de Especialidades (MX)
- Complejo Asistencial Sótero del Río (CL)
- Hospital Posadas (AR)
Publication Details
- Journal
- Cureus
- Published
- 2025-12-22
- DOI
- https://doi.org/10.7759/cureus.99854
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00